BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28341718)

  • 1. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
    Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.
    Yassine HN; Feng Q; Azizkhanian I; Rawat V; Castor K; Fonteh AN; Harrington MG; Zheng L; Reed BR; DeCarli C; Jagust WJ; Chui HC
    JAMA Neurol; 2016 Oct; 73(10):1208-1216. PubMed ID: 27532692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive deficits in non-demented diabetic elderly appear independent of brain amyloidosis.
    Chiang GC; Chang E; Pandya S; Kuceyeski A; Hu J; Isaacson R; Ganzer C; Schulman A; Sobel V; Vallabhajosula S; ; Ravdin L
    J Neurol Sci; 2017 Jan; 372():85-91. PubMed ID: 28017255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.
    Apostolova LG; Risacher SL; Duran T; Stage EC; Goukasian N; West JD; Do TM; Grotts J; Wilhalme H; Nho K; Phillips M; Elashoff D; Saykin AJ;
    JAMA Neurol; 2018 Mar; 75(3):328-341. PubMed ID: 29340569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
    Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
    JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Mielke MM; Vemuri P; Lowe V; Senjem ML; Gunter JL; Reyes D; Machulda MM; Roberts R; Petersen RC
    Brain; 2015 Dec; 138(Pt 12):3747-59. PubMed ID: 26428666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
    Apostolova LG; Hwang KS; Avila D; Elashoff D; Kohannim O; Teng E; Sokolow S; Jack CR; Jagust WJ; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neurology; 2015 Feb; 84(7):729-37. PubMed ID: 25609767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
    J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults.
    Armstrong NM; Huang CW; Williams OA; Bilgel M; An Y; Doshi J; Erus G; Davatzikos C; Wong DF; Ferrucci L; Resnick SM
    Neuroimage Clin; 2019; 22():101769. PubMed ID: 30927602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anxiety with subcortical amyloidosis in cognitively normal older adults.
    Hanseeuw BJ; Jonas V; Jackson J; Betensky RA; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    Mol Psychiatry; 2020 Oct; 25(10):2599-2607. PubMed ID: 30116029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between objectives sleep parameters and brain amyloid load in subjects at risk for Alzheimer's disease: the INSIGHT-preAD Study.
    Ettore E; Bakardjian H; Solé M; Levy Nogueira M; Habert MO; Gabelle A; Dubois B; Robert P; David R
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31267124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
    Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.